Food & Health
The FDA approved AbbVie’s (ABBV.N) tavapadon as a once-daily Parkinson’s pill on Friday, a milestone that analysts say anchors a long-term revenue stream management has pegged above $5 billion.
For long-horizon investors, the approval transforms a key asset acquired through AbbVie’s...
Eli Lilly (LLY.N) signed a research and licensing pact with Beijing-based InnoCare Pharma (688428.SS)...
Roche (ROG.S) said its experimental drug enicepatide meaningfully cut blood-sugar levels and body weight...
Pfizer (PFE) is pursuing roughly $2 billion from Poland and Romania over cancelled Covid-19 vaccine contracts,...
A neuromuscular drug candidate acquired by Novartis (NVS) through its $12 billion Avidity Biosciences...
Ionis Pharmaceuticals (IONS.O) secured FDA approval Thursday for zilganersen (Zanvastro), the first-ever...
Nestlé (NESN.S) said Thursday it will commit 2 billion reais ($392.73 million) to its Brazil nutrition...
Trending
CATEGORIES
Categories
SIGNUP TO OUR NEWSLETTER
Subscribe
Get breaking market insights directly to your inbox